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Abstract
Background: To evaluate binocular visual outcome for near, intermediate and distance compared to monocular
visual outcome at the same distances in patients implanted with a diffractive trifocal intraocular lens (IOL).
Methods: The study comprised of 100 eyes of 50 patients that underwent bilateral refractive lens exchange or
cataract surgery with implantation of a multifocal diffractive IOL (AT LISA tri 839MP, Carl Zeiss Meditech, Germany).
A complete ophthalmological examination was performed preoperatively and 3 month postoperatively. The main
outcome measures were monocular and binocular uncorrected distance (UDVA), corrected distance (CDVA),
uncorrected intermediate (UIVA), and uncorrected near visual acuities (UNVA), keratometry, and manifest refraction.
Results: The mean age was 59.28 years ± 9.6 [SD] (range 44–79 years), repectively. There was significant
improvement in UDVA, UIVA, UNVA and CDVA. Comparing the monocular results to the binocular results there was
a statistical significant better binocular outcome in all distances (UDVA p = 0.036; UIVA p < 0.0001; UNVA p = 0.001).
The postoperative manifest refraction was in 86 % of patients within ± 0.50 [D].
Conclusions: The trifocal IOL improved near, intermediate, and distance vision compared to preoperatively. In
addition a statistical significant increase for binocular visual function in all distances could be found.
Trial registration: German Clinical Trials Register (DRKS) DRKS00007837
Background
In todays world patients’ expectation in regards to refract-
ive outcome and spectacle independence have increased
substantially and even cataract patients have the same de-
mands as refractive patients.
For the ophthalmologist this means that the final goal is
to achieve an accuracy of the target refraction with less
than ±0.5 D postoperatively [1].
Recent advances in microsurgery and the latest develop-
ments in intraocular lenses (IOLs) have allowed surgeons
to achieve more accurate and predictable postoperative re-
fractive results. Still, in order to achieve spectacle independ-
ence the simultaneous treatment of presbyopia is crucial.
In the field of lens surgery the use of multifocal IOLs has
shown that it can improve uncorrected near visual acuity
(UNVA) and uncorrected distance visual acuity (UDVA)
and therefore reduce spectacle dependence [2–6]. Toward
this purpose, many designs based on different optical
principles have been applied in the manufacturing of
IOLs. Basically, four types of IOLs are available; refractive,
diffractive, refractive–diffractive, and accommodating.
Although all can improve UNVA and UDVA, there are
collateral effects that should be avoided, such as halos,
glare, and loss of contrast sensitivity [3–5, 7]. Regarding
uncorrected intermediate visual acuity (UIVA) a great
variability in results has been observed with the use of
different multifocal IOL models. Therefore, improvement
in intermediate vision is still needed to increase the level
of patient satisfaction.
With a change in society and especially the demands in
daily work force (use of computers, tablets, smart phones)
excellent intermediate vision is becoming a greater demand
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of our patients. Newer IOL models, which create a true
intermediate focus, have proven to fulfill this needs [8–10].
In the present study, bilateral implantation of the AT Lisa
tri 839MP (Carl Zeiss Meditec AG), a new diffractive IOL
with a trifocal design, was evaluated. (Figure. 1) To our
knowledge, this is the first larger study (50 patients) to
compare binocular visual function to monocular visual
function in pseudophakic patients implanted with this tri-
focal MIOL model and one of the few studies of trifocal
IOL technology [8–13].
The purpose of this study was to evaluate and to compare
the monocular to the binocular visual results obtained for
distance, intermediate, and near visual acuity to evaluate
the effect of binocular function after implantation of the tri-
focal IOL. Surgical complications during the follow- up,
subjective patients questionnaire for patient satisfaction
were also evaluated.
Methods
Patients
In this prospective clinical study, 50 patients were enrolled.
Included were patients with bilateral cataract or presby-
opia/pre-presbyopia suitable for refractive lens exchange
and seeking for spectacle independence. Exclusion criteria
were a history of glaucoma or retinal detachment, corneal
disease, regular corneal astigmatism greater 0.75D, irregular
corneal astigmatism, abnormal iris, macular degeneration
or retinopathy, neurophthalmic disease, history of ocular
inflammation, previous ocular surgery, unilateral amblyopia
or stereopsis less than 200 arc sec. In all cases, binocular
cataract surgery with implantation of the trifocal IOL AT
LISA tri 839MP (Carl Zeiss Meditec) was performed (Fig. 1)
The ethics committee of the doctors chamber Westfalen-
Lippe and the medical faculty of the Westfälischen
Wilhelms-University, Münster approved the study under
the reference number: 2014-078-b-S. All patients were ad-
equately informed and signed a consent form. The study
adhered to the tenets of the Declaration of Helsinki.
Clinical protocol
Before surgery, a complete ophthalmological examination
was performed, including manifest refraction, keratometry,
uncorrected (UDVA) and corrected distance visual acuity
(CDVA), Stereopsis (Lang Test II) Goldmann applanation
tonometry, slit lamp examination, corneal topography, bi-
ometry (IOL Master v.4.3, Carl Zeiss Meditec), and fundos-
copy. Postoperatively, patients were examined the day after
surgery as well as at 3 month (range:2.5–4 months) after
surgery of the second eye. The postoperative examination
protocol at 3 months was identical to the preoperative
protocol, with the additional evaluation of monocular and
binocular uncorrected intermediate visual acuity (UIVA) at
66 cm, monocular and binocular uncorrected near visual
acuity (UNVA) at 40 cm. In addition, patients were asked
about their satisfaction with the results of the surgery as
well as about the perception of photic phenomena, such as
glare or halos. Patient satisfaction criteria were spectacle in-
dependence for: reading newspaper, reading books, watch-
ing TV, driving at day time, driving at night time, shopping
at the supermarket, performing computer work, performing
house and garden work and performing fine work. The an-
swers consisted of yes, partly, no and not applicable.
As all eyes had an axial length >21.00 mm and <
29.00 mm, the Haigis formula was used for the calcula-
tion of the IOL power according to the measurements of
corneal power, axial length, and anterior chamber depth
obtained with the IOLMaster v4.3 (Carl Zeiss Meditec)
system. Target refraction was closest to emmetropia in
all cases.
Intraocular lens
As described in previous studies the AT Lisa tri 839MP
(Fig. 1) is a preloaded IOL with a single-piece diffractive
multifocal design. It has a 6.0 mm biconvex optic and an
overall length of 11.0 mm. It is a foldable hydrophilic
acrylate IOL with a water content of 25 % and hydropho-
bic surface properties [9]. The near add is +3.33D and the
intermediate add is +1.66D. The central 4.34 mm follow
the described trifocal design, while the peripheral part is
only bifocal.
Surgery
All surgeries were performed using a standard technique
of sutureless 2.2 mm phacoemulsification. All incisions
were made at the 12 o’clock position. Retrobulbar anaes-
thesia and mydriatic drops were instilled in all cases
prior to the surgical procedure. After capsulorhexis cre-
ation with a cystotome under current irrigation through
the cystotome needle, phacoemulsification and bimanual
cortex peeling with capsule polishing, the IOLs were
inserted into the capsular bag using the BLUEMIXS 180
injector (Carl Zeiss Meditec) through the main incisions.
At the end of the surgery subconjunctival injection of
Fig. 1 AT LISA tri 839MP (Calr Zeiss MEditech, Jena, Germany)
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dexamethasone and cefuroxime was administered. A
postoperative therapy based on a combination of topical
antibiotic and steroid was prescribed to be applied four
times daily during two week.
Statistical analysis
SPSS statistics software package version 15.0.1 for Win-
dows (IBM, Armonk, NY, USA) was used for statistical
analysis. The Kolmogorov-Smirnov test was used to check
the normality of the data distribution. When parametric
analysis was possible, the Student t test for paired data
was performed for all parameter comparisons between
preoperative and postoperative examinations as well as
between consecutive postoperative visits. Otherwise, when
parametric analysis was not possible, the Mann–Whitney
test was applied to assess the significance of differences
between consecutive examinations. In all cases, the same
level of significance (p < 0.05) was considered.
Results
The study enrolled 100 eyes of 50 patients. 42 % were
male and 58 % were female. The median patient age was
59.28 years (±7.6 (SD) (range 44.4–79.2 years). In 36 % a
regular cataract surgery was performed, while in 64 % a
clear lens exchange for presbyopia correction was
performed.
Preoperative measurements
Table 1 shows the preoperative IOL-Master results.
There were no statistical significant differences between
the flattest meridian (K1) and the steepest meridian (K2)
preoperatively (Mann–Whitney-Test). Regarding preope-
rative refraction there was no statistical significant differ-
ence between sphere (p = 0.442), cylinder (p = 0.928) or
spherical equivalent (p = 0.418. All patients had a tested
stereopsis of 200 arc sec (Lang Test II).
Visual and refractive outcomes
Table 2 shows the refractive results in all patients over time.
There were significant reductions in sphere, cylinder, and
spherical equivalent (SE). Postoperatively, the spherical
equivalent decreased significantly to 0.08 [D] (P < .001) In
all patients (table 2). Three months after surgery, the SE
ranged from-1.38–0.75 [D] with 86 % of patients being
±0.50 [D] (Fig. 2). In the comparison between OD and OS
there was no statistical significant difference between the
refractive outcome respectively (p = 0.857).
All patients achieved a postoperative stereopsis equal
to the preoperative value of 200 arc sec. Table 2 shows
the visual acuities. There was a statistically significant
improvement between preoperatively and 3 months
postoperatively in the following variables: UDVA, CDVA.
By comparing monocular to binocular UDVA, UIVA and
UNVA after surgery, there was a statistical significant in-
crease in all distances (Table 3). Figure 3 shows the cu-
mulative visual acuity for the better eye and binocular.
91 % of patients reached binocular UDVA of 0.0 log-
MAR, 79 % binocular UIVA of 0.0 logMAR and 87 %
binocular UNVA of 0.0 logMAR. 100 % of patients
reached at last binocular UDVA, UIVA and UNVA of
0.3 logMAR or better (Fig. 3). The effect of binocular fu-
sion gave an average gain of one line for distance, inter-
mediate and near visual acuity. There were no statistical
significant differences between the postoperative mon-
ocular and binocular UDVA, UIVA, UNVA or the bin-
ocular visual acuity gain between the cataract and the
refractive lens exchange patients.
Patient satisfaction
Seventy prercent of the patients were able to read news-
paper and book print without glasses, while the other
30 % answered the question with a partly use of spectacles.
All patients were able to watch TV, drive during daytime,
Table 1 Preoperative IOL-Master values (axial length = AL; flattest meridian = K1; steepest meridian = K2; anterior chamber deepth
= ACD; interquartiles distance = IQA; right eye = OD; left eye OS)
Mean Range Median IQA p-value (Mann–Whitney-Test)
AL [cm] OD 23.933 21.600–28.590 23.795 1.155 0.962
OS 23.907 21.430–28.190 23.665 1.328
total 23.92 21.43–28.59 23.75 1.293 —
K1 [mm] OD 7.908 7.300–9.110 7.900 0.267 0.825
OS 7.916 7.320–8.990 7.925 0.245
total 7.912 7.300–9.110 7.92 0.27 —
K2 [mm] OD 7.747 7.120–8.940 7.720 0.28 0.931
OS 7.746 7.200–8.630 7.746 0.318
total 7.747 7.120–8.940 7.73 0.313 —
ACD [mm] OD 3.213 2.280–3.750 3.300 0.503 0.502
OS 3.260 2.280–3.950 3.330 0.48
total 3.236 2.280–3.950 3.3 0.49 —
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go shopping at the supermarket and perform house and
garden work without the use of glasses. For nighttime
driving 90 % did not need glasses anymore while 10 %
were still dependent on the use of spectacles. Computer
work was graded with 60 % of patients being spectacle
free, 20 % being partly spectacle free and the other 20 %
answered with not applicable. Performing fine work 50 %
were spectacle free, 40 % were partly spectacle free and
10 % answered with not applicable.
Complications
No serious complications, such as posterior capsule
rupture, endophthalmitis, or corneal decompensation,
occurred during the follow-up.
Table 2 Refractive and visual results (interquartiles distance = IQA; uncorrected distance visual acuity = UDVA; corrected distance
visual acuity = CDVA; uncorrected near visual acuity = UNVA; uncorrected intermediate visual acuity = UIVA)
Mean (Range) Pre-operative Post-operative p-value
(Mann–
Whitney-
Test)
Median (IQA)
UDVA [LogMAR] 0.72 0.10 to 2.00 0.06 −0.10 to 0.30 <.001
0.60 0.70 0.10 0.10
Sphere (D) −0.05 −13.25 to 6.25 0.20 −0.75 to 1.00 <.001
1.25 2.25 0.25 0.5
Cylinder (D) −0.89 −4.00 to 0 −0.58 −1.75 to 0.00 <.001
−0.75 0.5 −0.50 0.31
Spherical equivalent (D) −0.44 −14.00 to 5.88 −0.08 −1.38 to 0.75 <.001
0.81 2.66 0.00 0.53
CDVA [LogMAR] 0.16 0.00 to 1.30 0.04 −0.20 to 0.30 <.001
0.10 0.3 0.00 0.1
UNVA [LogMAR] — 0.06 −0.10 to 0.30 —
0.05 0.10
UIVA [LogMAR] — 0.09 −0.10 to 0.30 —
0.10 0.10
binocular UDVA [LogMAR] — 0.04 −0.10 to 0.20 —
0.00 0.10
binocular UNVA [LogMAR] — 0.01 −0.10 to 0.20 —
0.00 0.19
binocular UIVA [LogMAR] — 0.04 −0.10 to 0.20 —
0.00 0.10
Fig. 2 Percentage of patients in deviation of target refraction
(Spherical Equivalent [SE])
Table 3 Comparision of monocular and binocular uncorrected
visual acuity 3 month postoperatively (interquartiles distance = IQA;
uncorrected distance visual acuity = UDVA; uncorrected near visual
acuity = UNVA; uncorrrected intermediate visual acuity = UIVA)
Mean (Range) Monocular Binocular p-value
(Mann–
Whitney-
Test)
Median (IQA)
UDVA [LogMAR] 0.06 −0.10 to 0.30 0.04 −0.10 to 0.20 0.036
0.10 0.10 0.00 0.10
UNVA [LogMAR] 0.06 −0.10 to 0.30 0.01 −0.10 to 0.20 <.001
0.05 0.10 0.00 0.19
UIVA [LogMAR] 0.09 −0.10 to 0.30 0.04 −0.10 to 0.20 <.001
0.10 0.10 0.00 0.10
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Discussion
Multifocal IOLs were designed to improve vision at
different distances by increasing the depth of field in the
eye [14]. The approach is different depending on the
particular IOL model; however, the principal goal is to
provide the best levels of spectacle independence [2]. As
the intermediate focus has become more important for
daily life activities, new optical designs try to fulfill those
needs. Developments for optical designs have been made
for refractive, diffractive, or combinations of booth. One
approach is to reduce the add power of MIOLs to shift
the focal point closer to an intermediate direction,
resulting in a loss of spectacle independence in the near.
The monovision approach in those cases increases spec-
tacle independence but reduces stereopsis in near and
intermediate distance like known from monofocal IOLs
[15]. More recently, accommodating IOL models are being
tested and new technologies are being developed. Another
technical approach to define true intermediate vision has
been the development of trifocal IOLs [8, 10–12, 16, 17].
This third focal point that is induced by a second dif-
fractive structure, also reduces the loss of light compared
to other diffractive, bifocal IOLs, by offering true inter-
mediate visual acuity [18]. By giving patients the focal
points for both eyes, stereopsis should be obtained.
To our knowledge, this is the first study to compare
the results of binocular visual acuity to the monocular
visual acuity in a study cohort of 100 eyes of 50 patients
having been implanted with a AT LISA tri 839MP in
both eyes.
Our UDVA results were notable, with a mean value of
0.06 monocular, with still a statistical significant increase
to 0.04 binocular (Table 3). We could also show a similar,
statistical significant effect of binocular fusion for UNVA
and UIVA (Table 3). We believe these values monocular
and especially binocular are sufficient to obtain a high
level of spectacle independence for daily life routine.
In the present study, there was an improvement in
UDVA and CDVA compared to preoperatively (Table 2).
Therefore, the trifocal IOL we tested was very effective.
These results are consistent with the refractive values ob-
tained. All were within the interval of -0.50 to +0.50 [D]
of SE 3 months after surgery. In a recent study of another
trifocal model (Finevision, PhysIOL S,A), Sheppard et al.
[12] reported a mean monocular UDVA and CDVA of
0.19 ± 0.09 and 0.08 ± 0.08, respectively. These results are
consistent with those presented by Voskresenskaya et al.
[10] for the MIOL-Record 3 model (Reper). Our results
for both variables (mean 0.06 ± 0.08 for UDVA and 0.04 ±
0.08 for CDVA) seem to be very similar to those published
by Lesieur [11] and for the Finevision IOL (mean 0.00 ±
for UDVA and 0.00 ± 0.00 for CDVA).
Often described, but never proven is the fact that bin-
ocular visual function in MIOL patients leads to an in-
crease of visual acuity in all distances. Our results clearly
show a statistical significant increase of UDVA, UIVA and
UNVA by comparing monocular to binocular results.
Similar results of increased binocular visual acuity com-
pared to monocular visual acuity have been shown in the
past. Cagenello R et al. [19] found an average increase of
11 % in a study of four phakic young patients. By recalcu-
lating our gain in a percentage, we found a similar binocu-
lar summation of around 10 % with an average age of
59 years compared to the 11 % of Cagenello et al. [19]
with four patients in an age range of 29–40 years old.
Rubin et al. [20] showed in a population based study of
2520 patients in the age between 65 and 84 years an aver-
age gain by binocular summation of 1.5 ETDRS letters
which was statistical significant, but not clinical signifi-
cant. As this was a population based study, there were no
differentiations between phakic, cataractouse or pseudo-
phakic eyes which limits the possible comparison to our
study with a statistical significant binocular gain of 1 line,
which we do consider clinical relevant as well. Pardhan S.
[21] showed in their study a functional gain of 31-32 % in
cataract patients, but no comparison in pseudophakic pa-
tients. To our knowledge, our data is the first to compare
a larger study group of 50 pseudophakic patients im-
planted with the same trifocal MIOL showing similar re-
sults compared to other studies of mainly phakic patients
in various age ranges [19–21].
All patients reported that the final result, as a whole, was
excellent or very good. Moreover, all reported that they
were comfortable performing intermediate-distance tasks.
The main advantage of multifocal IOLs is the capability
of generating different foci to achieve acceptable levels of
vision at far and near [16]. In addition, others have shown
the advantages of multifocal IOLs over monofocal IOLs
[22]. However, better intermediate vision results are still
necessary. As the binocular summation adds a statistical
increase of visual acuity in all distance, it is favorable to
Fig. 3 Cumulative uncorrected visual acuity [logMAR] in distance
intermediate and near (n = 50) mUDVA – monocular UDVA, bUDVA
– bincoluar UDVA, mUIVA – monocular UIVA, bUIVA – binocular
UIVA, mUNVA – monocular UNVA, bUNVA – binocular UNVA
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implant the same IOL model with a similar target refrac-
tion in both eyes to have an extra gain of visual acuity
Conclusion
In conclusion, we believe that the excellent visual results
obtained at different distances with the trifocal design
indicate an emerging technique in the field of the dif-
fractive IOLs. Binocular summation has an impact on
clinical and statistical significant increase of visual acuity
in all distances to provide a fully functional vision in-
cluding functional stereopsis for our patients. By trying
to find the best possible outcome for cataract and espe-
cially refractive lens exchange patients the latest version
of trifocal, multifocal IOLs seem to be a favorable option
to create spectacle independence in various distances.
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